Blood and urine markers studied in glioblastoma
Original title: Neopterin, tryptophan and kynurenine as biomarkers in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was measured in a small group of people, and the results still need to be checked in larger studies.
The short version
Doctors checked whether certain substances in blood and urine could help predict how people with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary will do.
What was studied. Twenty-four patients with glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary and 24 healthy people of similar age and gender took part. Blood and urine were collected at four time points, before surgery, three days after surgery, before extra treatment, and after extra treatment. The team measured tryptophan, kynurenine, and neopterin.
What they found. The levels of all three substances went up and down around the time of surgery in the glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary patients. There was a possible link between the kynurenine level in blood before surgery and how long people lived. The link was not strong enough to be certain, so the authors say it needs to be checked in larger studies.
What this means, and what it doesn't
What it could mean: This is early work on a possible way to predict outcomes. It does not change any treatment. If it holds up in bigger studies, a blood test like this might one day help doctors judge how a tumor is likely to behave.
What it doesn't mean: This does not mean a new treatment. These are markers that might predict outcome, not something that treats the tumor. The study was small and the main link was only a trend, not a firm result. The authors themselves ask for larger studies. This is far from everyday care, and it is not a promise of a cure.
Source: PubMed, July 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.